One patient with MOG antibody-associated diseases manifested as Todd's paralysis and literature review

doi:10.3760/cma.j.issn.1007-1245.2023.20.021

Abstract

Abstract:

The clinical phenotypes of myelin oligodendrocyte glycoprotein (MOG) antibody-associated diseases are complex and difficult to identify. In this paper, we report a case of MOG antibody-associated diseases with Todd's paralysis and analyze its characteristics of symptomatology, imaging, and electrophysiology, so as to increase the understanding of such diseases, achieve early identification and immunotherapy, and improve prognosis.

Key words:

Myelin oligodendrocyte glycoprotein, Todd's paralysis, Epileptic seizure, Literature review

摘要：

髓鞘少突胶质细胞糖蛋白（myelin oligodendrocyte glycoprotein，MOG）抗体相关疾病临床表型复杂，不易识别。本文通过报道2022年6月7日威海市中心医院收治的1例表现为Todd's瘫痪的MOG抗体相关疾病，分析其症状学、影像学、电生理的特征，增加对此类疾病的认识，达到早期识别、早期开始免疫治疗、最终改善预后的目的。

关键词:

髓鞘少突胶质细胞糖蛋白, Todd's瘫痪, 痫性发作, 文献复习

Zhou Li, Lyu Renhua, Ju Weiping.

One patient with MOG antibody-associated diseases manifested as Todd's paralysis and literature review [J]. International Medicine and Health Guidance News, 2023, 29(20): 2924-2928.

周丽吕仁花鞠卫萍.

表现为Todd's瘫痪的MOG抗体相关疾病1例并文献复习 [J]. 国际医药卫生导报, 2023, 29(20): 2924-2928.

References

[1] 中国免疫学会神经免疫分会. 抗髓鞘少突胶质细胞糖蛋白免疫球蛋白G抗体相关疾病诊断和治疗中国专家共识[J]. 中国神经免疫学和神经病学杂志,2020,27(2):86-95. DOI:10.3969/j.issn.1006-2963.2020.02.002.
[2] 赵聪,李柱一. 髓鞘少突胶质细胞糖蛋白抗体相关疾病研究进展[J]. 中国神经免疫学和神经病学杂志,2021,28(1):71-74. DOI:10.3969/j.issn.1006-2963.2021.01.013.
[3] Wynford-Thomas R, Jacob A, Tomassini V. Neurological update: MOG antibody disease[J]. J Neurol, 2019 ,266(5):1280-1286. DOI: 10.1007/s00415-018-9122-2.
[4] Jarius S, Paul F, Aktas O, et al. MOG-Enzephalomyelitis: Internationale empfehlungen zu diagnose und antikörpertestung [MOG encephalomyelitis: international recommendations on diagnosis and antibody testing][J]. Nervenarzt, 2018 ,89(12):1388-1399. DOI: 10.1007/s00115-018-0607-0.
[5] Netravathi M, Holla VV, Nalini A, et al. Myelin oligodendrocyte glycoprotein-antibody-associated disorder: a new inflammatory CNS demyelinating disorder[J]. J Neurol, 2021 ,268(4):1419-1433. DOI: 10.1007/s00415-020-10300-z.
[6] Ramanathan S, Prelog K, Barnes EH, et al. Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis[J]. Mult Scler, 2016 ,22(4):470-482. DOI: 10.1177/1352458515593406.
[7] Biotti D, Bonneville F, Tournaire E, et al. Optic neuritis in patients with anti-MOG antibodies spectrum disorder: MRI and clinical features from a large multicentric cohort in France[J]. J Neurol, 2017 ,264(10):2173-2175. DOI: 10.1007/s00415-017-8615-8.
[8] 刘慧勤,崔红培,张弥兰,等. 髓鞘少突胶质细胞糖蛋白抗体相关疾病的临床、影像及预后特点[J]. 中华神经医学杂志,2022,21(2):164-171. DOI:10.3760/cma.j.cn115354- 20211216-00822.
[9] Reindl M, Waters P. Myelin oligodendrocyte glycoprotein antibodies in neurological disease[J]. Nat Rev Neurol, 2019 ,15(2):89-102. DOI: 10.1038/s41582-018-0112-x.
[10] de Mol CL, Wong Y, van Pelt ED, et al. The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults[J]. Mult Scler, 2020 ,26(7):806-814. DOI: 10.1177/1352458519845112.
[11] Budhram A, Mirian A, Le C, et al. Unilateral cortical FLAIR-hyperintense lesions in Anti-MOG-associated encephalitis with seizures (FLAMES): characterization of a distinct clinico-radiographic syndrome[J]. J Neurol, 2019 ,266(10):2481-2487. DOI: 10.1007/s00415-019- 09440-8.
[12] Cobo-Calvo A, Ruiz A, Maillart E, et al. Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: The MOGADOR study[J]. Neurology, 2018 ,90(21):e1858-e1869. DOI: 10.1212/WNL.0000000000005560.
[13] 尹翮翔,张遥,徐雁,等. MOG抗体相关脑炎临床特点与预后分析[J]. 中国神经免疫学和神经病学杂志,2021,28(4):288-292,322. DOI:10.3969/j.issn.1006-2963.2021.04.004.
[14] Ikeda T, Yamada K, Ogawa R, et al. The pathological features of MOG antibody-positive cerebral cortical encephalitis as a new spectrum associated with MOG antibodies: a case report[J]. J Neurol Sci, 2018 ,392:113-115. DOI: 10.1016/j.jns.2018.06.028.
[15] Shu Y, Long Y, Wang S, et al. Brain histopathological study and prognosis in MOG antibody-associated demyelinating pseudotumor[J]. Ann Clin Transl Neurol, 2019 ,6(2):392-396. DOI: 10.1002/acn3.712.
[16] Wang L, Zhang BJ, Zhou L, et al. Encephalitis is an important clinical component of myelin oligodendrocyte glycoprotein antibody associated demyelination: a single-center cohort study in Shanghai, China[J]. Eur J Neurol, 2019 ,26(1):168-174. DOI: 10.1111/ene.13790.
[17] Hamid SHM, Whittam D, Saviour M, et al. Seizures and encephalitis in myelin oligodendrocyte glycoprotein IgG disease vs aquaporin 4 IgG disease[J]. JAMA Neurol, 2018 ,75(1):65-71. DOI: 10.1001/jamaneurol.2017.3196.
[18] Chen C, Liu C, Fang L, et al. Different magnetic resonance imaging features between MOG antibody- and AQP4 antibody-mediated disease: A Chinese cohort study[J]. J Neurol Sci, 2019 ,405:116430. DOI: 10.1016/j.jns.2019.116430.
[19] Zhou L, Huang Y, Li H, et al. MOG-antibody associated demyelinating disease of the CNS: a clinical and pathological study in Chinese Han patients[J]. J Neuroimmunol, 2017 ,305:19-28. DOI: 10.1016/j.jneuroim.2017.01.007.
[20] Jurynczyk M, Geraldes R, Probert F, et al. Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis[J]. Brain, 2017 ,140(3):617-627. DOI: 10.1093/brain/aww350.
[21] Kezuka T, Tanaka K, Matsunaga Y, et al. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders[J]. Neurology, 2014 ,83(5):475. DOI: 10.1212/WNL. 0000000000000636.
[22] Gutman JM, Kupersmith M, Galetta S, et al. Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in patients with optic neuritis and seizures[J]. J Neurol Sci, 2018 ,387:170-173. DOI: 10.1016/j.jns.2018.01.042.
[23] 何晨敏,金搏,汪珊,等. 磁共振阴性局灶性癫痫的常用影像学后处理技术研究进展[J]. 中华神经科杂志,2020,53(6):469-474. DOI:10.3760/cma.j.cn113694-20190930- 00610.
[24] 许丹,肖太星,唐雪珂. 3D高分辨率MRI在癫痫患者中的应用效果分析[J]. 国际医药卫生导报,2022,28(19):2773-2777. DOI:10.3760/cma.j.issn.1007-1245. 2022.19.024.
[25] 周季,丁昌红,张炜华,等. 以皮质脑炎为表型的儿童抗髓鞘少突胶质细胞糖蛋白抗体相关疾病的临床特点[J]. 中华医学杂志,2020,100(25):1952-1955. DOI:10.3760/cma.j.cn112137-20200525-01644.
[26] Onder H. Todd's Paralysis: a crucial entity masquerading stroke in the emergency department[J]. J Emerg Med, 2017 ,52(4):e153-e155. DOI: 10.1016/j.jemermed. 2016.12.001.
[27] Gallmetzer P, Leutmezer F, Serles W, et al. Postictal paresis in focal epilepsies--incidence, duration, and causes: a video-EEG monitoring study[J]. Neurology, 2004 ,62(12):2160-2164. DOI: 10.1212/wnl.62.12.2160.
[28] 盛鑫,薛峥,闵喆. 延迟诊断的Todd瘫痪一例临床特点分析并文献复习[J]. 中国神经免疫学和神经病学杂志,2021,28(6):498-499. DOI:10.3969/j.issn.1006-2963. 2021.06.017.
[29] Van Cauwenberge MGA, Dekeyzer S, Nikoubashman O, et al. Can perfusion CT unmask postictal stroke mimics? A case-control study of 133 patients[J]. Neurology, 2018 ,91(20):e1918-e1927. DOI: 10.1212/WNL. 0000000000006501.
[30] Jarius S, Ruprecht K, Kleiter I, et al. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin[J]. J Neuroinflammation, 2016 ,13(1):279. DOI: 10.1186/s12974-016-0717-1.